

25.1K
Downloads
592
Episodes
Podcasts for antibody-based pharmaceuticals including Therapeutic antibody/Antibody-drug conjugates/vaccine/CAR-T/Immunotherapy. Creative-Biolabs, the provider, is an outsourced research organization for antibody-drug development.
Episodes

Nov 3, 2022
Nov 3, 2022
8 min
Creative Biolabs files technical advances and professional academic reports on mRNA therapy and puts them in a podcast column.

Nov 2, 2022
Nov 2, 2022
11 min
Creative Biolabs files technical advances and professional academic reports on mRNA therapy and puts them in a podcast column.

Oct 30, 2022
Oct 30, 2022
9 min
Creative Biolabs files technical advances and professional academic reports on mRNA therapy and puts them in a podcast column.

Oct 27, 2022
Oct 27, 2022
54 min
Creative Biolabs has invited Dr. James Naismith to walk us through the development process of his novel SARS-CoV-2 neutralising sdAbs and how his team has found a candidate demonstrating promising therapeutic efficacy in a hamster model of COVID-19.

Oct 21, 2022
Oct 21, 2022
12 min
Oligonucleotides are nucleic acid polymers with potential to treat or manage a wide range of diseases. Oligonucleotide-based therapeutics employ chemically synthesized oligonucleotides with single-stranded DNA or RNA backbone of specific potential. Here, we will discuss the different types of oligonucleotide-based therapies, and some featured solutions provided by Creative Biolabs.

Oct 21, 2022
Oct 21, 2022
59 min
Creative Biolabs has invited Dr. Jeffrey R. Holt to walk us through how gene therapy has become a promising treatment for genetic hearing loss and how his team developed unique gene therapy strategies for genetic hearing loss.

Oct 21, 2022
Oct 21, 2022
56 min
Creative Biolabs has invited Dr. Markita Landry to walk us through how her team developed a near Infrared Catecholamine nanosensor (nIRCat) and used real-time imaging to find out what drives late-disease decreases in evoked dopamine release, and how to use these findings as optimal therapeutic intervention timepoints for siRNA-based Huntington's disease therapies.

Oct 19, 2022
Oct 19, 2022
10 min
Creative Biolabs files technical advances and professional academic reports on mRNA therapy and puts them in a podcast column.

Oct 19, 2022
Oct 19, 2022
12 min
Creative Biolabs files technical advances and professional academic reports on mRNA therapy and puts them in a podcast column.

Oct 19, 2022
Oct 19, 2022
13 min
Creative Biolabs files technical advances and professional academic reports on mRNA therapy and puts them in a podcast column.